1. Home
  2. MGX vs NKLA Comparison

MGX vs NKLA Comparison

Compare MGX & NKLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MGX
  • NKLA
  • Stock Information
  • Founded
  • MGX 2018
  • NKLA 2015
  • Country
  • MGX United States
  • NKLA United States
  • Employees
  • MGX N/A
  • NKLA N/A
  • Industry
  • MGX
  • NKLA Auto Manufacturing
  • Sector
  • MGX
  • NKLA Consumer Discretionary
  • Exchange
  • MGX NYSE
  • NKLA Nasdaq
  • Market Cap
  • MGX 87.0M
  • NKLA 98.8M
  • IPO Year
  • MGX 2024
  • NKLA N/A
  • Fundamental
  • Price
  • MGX $2.36
  • NKLA $0.38
  • Analyst Decision
  • MGX Strong Buy
  • NKLA Hold
  • Analyst Count
  • MGX 7
  • NKLA 4
  • Target Price
  • MGX $16.67
  • NKLA $6.00
  • AVG Volume (30 Days)
  • MGX 654.7K
  • NKLA 30.7M
  • Earning Date
  • MGX 03-04-2025
  • NKLA 03-04-2025
  • Dividend Yield
  • MGX N/A
  • NKLA N/A
  • EPS Growth
  • MGX N/A
  • NKLA N/A
  • EPS
  • MGX N/A
  • NKLA N/A
  • Revenue
  • MGX $55,080,000.00
  • NKLA $75,529,000.00
  • Revenue This Year
  • MGX $16.91
  • NKLA $215.41
  • Revenue Next Year
  • MGX N/A
  • NKLA $167.59
  • P/E Ratio
  • MGX N/A
  • NKLA N/A
  • Revenue Growth
  • MGX 45.13
  • NKLA 153.71
  • 52 Week Low
  • MGX $1.61
  • NKLA $0.35
  • 52 Week High
  • MGX $12.50
  • NKLA $34.50
  • Technical
  • Relative Strength Index (RSI)
  • MGX 42.18
  • NKLA 34.43
  • Support Level
  • MGX $2.34
  • NKLA $0.35
  • Resistance Level
  • MGX $2.82
  • NKLA $0.53
  • Average True Range (ATR)
  • MGX 0.21
  • NKLA 0.12
  • MACD
  • MGX 0.00
  • NKLA -0.00
  • Stochastic Oscillator
  • MGX 18.03
  • NKLA 5.73

About MGX METAGENOMI INC

Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. Genetic diseases are caused by a diverse set of mutations that have been largely inaccessible by genome engineering approaches to date. The genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems (including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs).

About NKLA Nikola Corporation

Nikola Corp is a technology innovator and integrator, working to develop inventive energy and transportation solutions. It works on a business model that enables customers and fleets to integrate next-generation truck technology, hydrogen fueling and charging infrastructure, and related maintenance. It operates in two business units: Truck and Energy. The Truck business unit and Energy business unit. The Truck business unit is engaged manufacturing and selling FCEV and BEV trucks that provide, environmentally friendly, cost effective solutions to the trucking sector. The Energy business unit is engaged in developing and constructing a network of hydrogen fueling stations to meet hydrogen fuel demand for the Company's customers.

Share on Social Networks: